rs786204761
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000390.4(CHM):c.116+1G>T variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000390.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- choroideremiaInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen, Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHM | NM_000390.4 | c.116+1G>T | splice_donor_variant, intron_variant | Intron 2 of 14 | ENST00000357749.7 | NP_000381.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHM | ENST00000357749.7 | c.116+1G>T | splice_donor_variant, intron_variant | Intron 2 of 14 | 1 | NM_000390.4 | ENSP00000350386.2 | |||
| CHM | ENST00000615443.1 | c.116+1G>T | splice_donor_variant, intron_variant | Intron 2 of 4 | 1 | ENSP00000484306.1 | ||||
| CHM | ENST00000483950.1 | n.146G>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 | |||||
| CHM | ENST00000467744.2 | n.126+1G>T | splice_donor_variant, intron_variant | Intron 2 of 2 | 5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The CHM gene encodes Rab escort protein 1, a RAB geranylgeranyl transferase subunit necessary for the postranslational modification and membrane targeting of Rab proteins (van den Hurk et al., 2003). Pathogenic variants in the CHM gene cause choroideremia, an X-linked form of retinal dystrophy characterized by retinal pigment epithelium and photoreceptor degeneration with eventual complete choroid atrophy and bare sclera (van den Hurk et al., 1997; Guo et al., 2015; Sanchez-Alcudia et al., 2016). Affected males have night blindness, tunnel vision, and may eventually become completely blind (van den Hurk et al., 2003). Rarely, female carriers may be affected, but typically have only mild cone dysfunction, mottled irregularity of the fundus, and yellowish flecks in the macula over time (Cremers et al., 1990, van den Hurk et al., 1997, Renner et al., 2009).
This sequence change affects a donor splice site in intron 2 of the CHM gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CHM are known to be pathogenic (PMID: 9067750, 23811034). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with choroideremia (PMID: 21905166, 27247961). ClinVar contains an entry for this variant (Variation ID: 279770). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Retinal dystrophy Pathogenic:1
Choroideremia Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at